InfuSystem To Present At 38th Annual ROTH Conference

InfuSystem Holdings ( (INFU) ) has provided an announcement.

InfuSystem Holdings, Inc., a U.S.-based provider of outpatient-focused durable medical equipment services across oncology, pain management and wound therapy, operates through Patient Services and Device Solutions platforms and supports providers and manufacturers nationwide. The company is headquartered in Rochester Hills, Michigan, and maintains Centers of Excellence in multiple U.S. states and Ontario, Canada.

On March 16, 2026, InfuSystem announced that President and CEO Carrie Lachance and CFO Barry Steele would represent the company at the 38th Annual ROTH Conference on March 23, 2026, in Dana Point, California. Management will conduct in-person one-on-one meetings with investors, signaling an effort to deepen institutional engagement and potentially broaden the company’s visibility in the capital markets.

The most recent analyst rating on (INFU) stock is a Buy with a $11.50 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.

Spark’s Take on INFU Stock

According to Spark, TipRanks’ AI Analyst, INFU is a Outperform.

The score is driven primarily by improving financial performance—strong recent revenue/profitability momentum, robust free cash flow, and sharply reduced leverage. Technicals support the uptrend but show stretched momentum. Valuation is a moderate headwind due to a higher P/E and no dividend yield data. Earnings call commentary is constructive on growth, margins, and cost savings, with near-term execution and reimbursement uncertainties as key risks.

To see Spark’s full report on INFU stock, click here.

More about InfuSystem Holdings

InfuSystem Holdings, Inc. is a national health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. Operating under a two-platform model, it offers Patient Services in oncology, pain management and wound therapy, and Device Solutions including rentals, pump and consumable sales, and biomedical services and repair.

Headquartered in Rochester Hills, Michigan, the company delivers local, field-based customer support and runs Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. Its Device Solutions platform supports and complements its clinic-to-home Patient Services business while also targeting direct payer clients for incremental revenue opportunities.

Average Trading Volume: 133,607

Technical Sentiment Signal: Strong Buy

Current Market Cap: $188.2M

For a thorough assessment of INFU stock, go to TipRanks’ Stock Analysis page.